Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY2780301 |
Trade Name | |
Synonyms | LY 2780301|LY-2780301 |
Drug Descriptions |
LY2780301 is an inhibitor of AKT and P70S6 kinases, which prevents signaling of the PI3K/AKT pathway thereby possibly resulting in antitumor activity (PMID: 25902900, PMID: 28877935). |
DrugClasses | Akt Inhibitor (Pan) 21 S6 Kinase Inhibitor 5 |
CAS Registry Number | NA |
NCIT ID | C95737 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + LY2780301 | Gemcitabine LY2780301 | 2 | 0 |
LY2780301 | LY2780301 | 1 | 0 |